Table 4.
Rectal challenge (rhesus macaques) | Vaginal challenge (pigtail macaques) | |
---|---|---|
TAF | Supra therapeutic dose 13.7 mg/kg | Clinical dose (1.5 mg/kg) |
∼1,600 fmol/106 PBMC | ∼300 fmol/106 PBMC | |
∼1,000 fmol/106 rectal lymphocytes | ∼5 fmol/mg of vaginal tissue | |
No protection | 58%–73% efficacy | |
FTC/TAF | Clinical dose (1.5 mg/kg) | Clinical dose (1.5 mg/kg) |
100% efficacy | 91%–100% efficacy |
PBMC, peripheral blood mononuclear cell.